Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce it has expanded its collaborative research agreement with the University of Melbourne and the Royal Women's Hospital.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the appointment of Ms Vicki Robinson to its Board as an independent non-executive director, effective 14 October 2025.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the appointment of David Wood as Joint Company Secretary for Proteomics International, effective today.
In this episode of The Ellis Martin Report on Money Talk Radio, Ellis speaks with Dr. Amie Phinney, Strategy and Business Advisor at Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) is pleased to announce its latest results on its first-in-class blood test for esophageal adenocarcinoma, PromarkerEso, are being presented today at the 21st ISDE World Congress for Esophageal Diseases, in Brisbane, Australia, 18-20 September 2025.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce it has been granted ISO 15189 certification for its Australian laboratory operations.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics and precision medicine, today announces a planned Board and Management transition.
